Cardinal Health Inc. has raised its financial outlook for fiscal year 2026, increasing its non-GAAP diluted earnings per share $(EPS)$ expectation to at least $10.00, up from the prior guidance range of $9.65 to $9.85. The revision reflects strong performance and execution across the company’s five operating segments. Additionally, Cardinal Health now anticipates its Specialty revenues will exceed $50 billion in fiscal 2026, representing a 16% compounded annual growth rate over three years. This growth is supported by robust demand in specialty distribution, expansion of management services organization platforms, and over 30% expected revenue growth in BioPharma Solutions for fiscal 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardinal Health Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL61805) on January 13, 2026, and is solely responsible for the information contained therein.